These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 2481177

  • 1. Do beta-blockers alter lipids and what are the consequences?
    Holtzman E, Rosenthal T, Goldbourt U, Segal P.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S86-92; discussion S93. PubMed ID: 2481177
    [Abstract] [Full Text] [Related]

  • 2. Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status.
    Holtzman E, Rosenthal T, Goldbourt U, Segal P.
    Isr J Med Sci; 1984 Dec; 20(12):1169-76. PubMed ID: 6519949
    [Abstract] [Full Text] [Related]

  • 3. Effects of chlorthalidone and metoprolol alone or in combination (logroton) on blood pressure, lipids, lipoproteins and circulating plasma ANF levels in essential hypertension.
    Bielmann P, Leduc G, Thibault G, Lepage J, Davignon J.
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):479-85. PubMed ID: 1839902
    [Abstract] [Full Text] [Related]

  • 4. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF.
    J Cardiovasc Pharmacol; 1982 Dec; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [Abstract] [Full Text] [Related]

  • 5. [The effect of diuretic therapy on serum lipoproteins: an undesirable effect?].
    Glück Z, Weidmann P, Mordasini R, Peheim E, Bachmann C, Keusch G, Riesen W.
    Schweiz Med Wochenschr; 1979 Jan 27; 109(4):104-8. PubMed ID: 219471
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    J Cardiovasc Pharmacol; 1982 Jan 27; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [Abstract] [Full Text] [Related]

  • 7. [Effect of celiprolol and metoprolol on serum lipids in patients with various forms of hyperlipoproteinemia].
    Pristautz H, Stradner F.
    Wien Med Wochenschr; 1986 Sep 15; 136(17):443-8. PubMed ID: 2879389
    [Abstract] [Full Text] [Related]

  • 8. [Changes in lipids and lipoproteins caused by the beta-blocking agents used as antihypertensives].
    Rouffy J, Chanu B, Bakir R, Sauvanet JP.
    J Pharmacol; 1983 Sep 15; 14 Suppl 2():183-99. PubMed ID: 6138467
    [Abstract] [Full Text] [Related]

  • 9. Effects of arotinolol on serum lipid and apolipoprotein levels in patients with mild essential hypertension.
    Sasaki J, Handa K, Arakawa K.
    Clin Ther; 1989 Sep 15; 11(5):580-3. PubMed ID: 2478285
    [Abstract] [Full Text] [Related]

  • 10. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M, Richter WO, Schwandt P, Holzgreve H.
    Int J Clin Pharmacol Ther; 1997 Jun 15; 35(6):231-4. PubMed ID: 9208337
    [Abstract] [Full Text] [Related]

  • 11. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P, de Courten M, Ferrari P, Böhlen L.
    J Cardiovasc Pharmacol; 1993 Jun 15; 22 Suppl 6():S98-105. PubMed ID: 7508069
    [Abstract] [Full Text] [Related]

  • 12. The effect of chlorthalidone on serum lipids and lipoproteins.
    Rosenthal T, Holtzman E, Segal P.
    Atherosclerosis; 1980 May 15; 36(1):111-5. PubMed ID: 7387770
    [Abstract] [Full Text] [Related]

  • 13. Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial.
    Johnston GD, Vyssoulis G, Feely J, Holden RD, Radley DR.
    J Hum Hypertens; 1995 Feb 15; 9(2):123-9. PubMed ID: 7752174
    [Abstract] [Full Text] [Related]

  • 14. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R.
    Artery; 1982 Feb 15; 10(4):266-85. PubMed ID: 7181672
    [Abstract] [Full Text] [Related]

  • 15. Beta-blockers, plasma lipids, and coronary heart disease.
    Cruickshank JM.
    Circulation; 1990 Sep 15; 82(3 Suppl):II60-5. PubMed ID: 1975524
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive therapy and the risk of coronary heart disease.
    Ames RP, Hill P.
    J Cardiovasc Pharmacol; 1982 Sep 15; 4 Suppl 2():S206-12. PubMed ID: 6177958
    [Abstract] [Full Text] [Related]

  • 17. [Serum lipid levels under chronical treatment with beta-receptor blocking agents in patients with coronary artery disease (author's transl)].
    Merker R, Schwittek W, Kladetzky RG, Kuhn H.
    Z Kardiol; 1981 Jun 15; 70(6):455-61. PubMed ID: 6114600
    [Abstract] [Full Text] [Related]

  • 18. [Changes in serum lipid levels, lipid composition and lipoprotein fractions in patients with ischemic cardiopathies or arterial hypertension].
    Dakovska L, Orbetzov M, Orbetzova V, Yarovska N.
    Paroi Arterielle; 1981 Jun 15; 7(1):15-22. PubMed ID: 7339537
    [Abstract] [Full Text] [Related]

  • 19. Effects of anti-hypertensive therapy on serum lipoproteins. Treatment with metoprolol, propranolol and hydrochlorothiazide.
    Fager G, Berglund G, Bondjers G, Elmfeldt D, Lager I, Olofsson SO, Smith U, Wiklund O.
    Artery; 1983 Jun 15; 11(4):283-96. PubMed ID: 6615245
    [Abstract] [Full Text] [Related]

  • 20. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI, Bhatnagar D, Durrington PN, Prais H, Haynes B, Morgan J, Borthwick L.
    Eur J Clin Nutr; 1994 Dec 15; 48(12):859-65. PubMed ID: 7889894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.